Most Recent

image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: Cholera Confusion, circa 1832

Cholera Confusion, circa 1832

By | February 1, 2013

The very cold, the merely chilled, and the colorful

2 Comments

image: Freezing Cells

Freezing Cells

By | February 1, 2013

The very cold, the merely chilled, and the colorful

1 Comment

image: Immune to Failure

Immune to Failure

By | February 1, 2013

The very cold, the merely chilled, and the colorful

2 Comments

image: Photonic Colored Creatures

Photonic Colored Creatures

By | February 1, 2013

The very cold, the merely chilled, and the colorful

1 Comment

image: Catching the Cold

Catching the Cold

By | February 1, 2013

The very cold, the merely chilled, and the colorful

2 Comments

image: Color from Structure

Color from Structure

By | February 1, 2013

The very cold, the merely chilled, and the colorful

4 Comments

image: Icing Organs

Icing Organs

By | February 1, 2013

The very cold, the merely chilled, and the colorful

6 Comments

image: Opinion: An Explosion of Devices

Opinion: An Explosion of Devices

By | January 28, 2013

The very cold, the merely chilled, and the colorful

0 Comments

image: Stem Cells Not Rejected

Stem Cells Not Rejected

By | January 25, 2013

The very cold, the merely chilled, and the colorful

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech